CV Sciences (CVSI) Other Working Capital Changes (2013 - 2026)
CV Sciences (CVSI) reported Other Working Capital Changes of -$12000.0 for Q1 2026, up 80.33% on a YoY basis from -$6654.5 in Q1 2025, and down 220.0% sequentially from $10000.0 in Q4 2025.
CV Sciences (CVSI) Other Working Capital Changes (2013 - 2026) Analysis & Trends
CV Sciences (CVSI) has 8 years of Other Working Capital Changes data on file, last reported at -$12000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 80.33% year-over-year to -$12000.0; the trailing twelve-month figure through Mar 2026 stood at $187000.0 (up 0.54% YoY), and the FY2025 full-year result was $138000.0, down 61.13% from the prior year.
- Other Working Capital Changes slipped to -$12000.0 in Q1 2026, from $10000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $28000.0 in Q1 2026 to a low of -$1.7 million in Q2 2023.
- A 5-year average of -$318187.5 and a median of -$121500.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes surged 1633.33% in 2022 and sank 156.48% in 2025, its largest moves.
- Tracing CVSI's Other Working Capital Changes over 5 years: stood at $88000.0 in 2022, then sank by 55.68% to $39000.0 in 2023, then soared by 205.13% to $119000.0 in 2024, then sank by 91.6% to $10000.0 in 2025, then tumbled by 220.0% to -$12000.0 in 2026.
- Business Quant data shows CVSI's Other Working Capital Changes at -$12000.0 in Q1 2026, $10000.0 in Q4 2025, and $23000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,000.00 |
| Mar 31, 2026 | 28,000.00 |
| Mar 31, 2026 | 28,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Dec 31, 2025 | -25,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Sep 30, 2024 | -83,000.00 |